Statement of Principles concerning malignant neoplasm of the small intestine No. 1 of 2015

Administered by Department of Veterans' Affairs

Legislation au F2014L01807 Not in force Legislative Instrument

Legislation content

REPATRIATION MEDICAL AUTHORITY

 

INSTRUMENT NO. 1 of 2015

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

EXPLANATORY NOTES FOR TABLING

 

 

  1. The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), revokes Instrument No. 40 of 2004, determined under subsection 196B(2) of the VEA concerning malignant neoplasm of the small intestine.
  2. The Authority is of the view that there is sound medical-scientific evidence that indicates that malignant neoplasm of the small intestine and death from malignant neoplasm of the small intestine can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(2) of the VEA a Statement of Principles, Instrument No. 1 of 2015 concerning malignant neoplasm of the small intestine.  This Instrument will in effect replace the revoked Statement of Principles.
  3. The provisions of the Military Rehabilitation and Compensation Act 2004 (the MRCA) relating to claims for compensation commenced on 1 July 2004.  Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.
  4. The Statement of Principles sets out the factors that must as a minimum exist, and which of those factors must be related to the following kinds of service rendered by a person:

 operational service under the VEA;

 peacekeeping service under the VEA;

 hazardous service under the VEA;

 British nuclear test defence service under the VEA;

 warlike service under the MRCA;

 non-warlike service under the MRCA,

before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the small intestine or death from malignant neoplasm of the small intestine, with the circumstances of that service.

5.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 18 May 2011 concerning malignant neoplasm of the small intestine in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

6.             The contents of this Instrument are in similar terms as the revoked Instrument.  Comparing this Instrument and the revoked Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2005;
  • revising factor 6(e) concerning 'being obese';
  • deleting factors concerning 'specified food', 'being infected with Helicobacter pylori, for carcinoma of the first part of the duodenum only' and 'alcohol';
  • revising the definitions of 'Crohn's disease', 'ICD-10-AM code' and 'relevant service' in clause 9;
  • deleting the definition of 'specified food'; and
  • specifying a date of effect for the Instrument in clause 11.

7.             Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of the small intestine in the Government Notices Gazette of 18 May 2011, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

9.             On 12 August 2014, the Authority wrote to organisations representing veterans, service personnel and their dependants regarding the proposed Instrument and the medical-scientific material considered by the Authority. This letter emphasised the deletion of factors relating to specified food; being infected with Helicobacter pylori, for carcinoma of the first part of the duodenum only; and alcohol. The Authority provided an opportunity to the organisations to make representations in relation to the proposed Instrument prior to its determination. No submissions were received for consideration by the Authority. No changes were made to the proposed Instrument following this consultation process.

10.         This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

11.         The determining of this Instrument finalises the investigation in relation to malignant neoplasm of the small intestine as advertised in the Government Notices Gazette of 18 May 2011.


12.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 1 of 2015

Kind of Injury, Disease or Death: Malignant neoplasm of the small intestine

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have malignant neoplasm of the small intestine;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting malignant neoplasm of the small intestine with the circumstances of eligible service rendered by a person, as set out in clause 4 of the Explanatory Notes;
  • replaces Instrument No. 40 of 2004; and
  • reflects developments in the available sound medical-scientific evidence concerning malignant neoplasm of the small intestine which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members; and
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Repatriation Medical Authority Instrument No. 1 of 2015 was enacted in 2015 to address the issue of malignant neoplasm of the small intestine in veterans and Defence Force members. The Authority, operating under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), determined that there is sufficient medical-scientific evidence linking this condition to certain types of service, leading to the creation of a new Statement of Principles to replace the previously revoked one. This legislative instrument aims to facilitate the process of making and assessing claims for medical treatment and compensation under the VEA and the MRCA by clearly outlining the necessary circumstances and factors that must exist for a reasonable hypothesis to connect the condition with service rendered. This includes defining the types of service and related factors such as operational, peacekeeping, hazardous, British nuclear test defence, warlike, and non-warlike service. The Authority's decision was based on an extensive review of available medical-scientific evidence, and the new instrument reflects the latest scientific understanding of the condition.

Scope and Application

The Repatriation Medical Authority Instrument No. 1 of 2015, under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), sets out a Statement of Principles concerning malignant neoplasm of the small intestine, replacing the revoked Instrument No. 40 of 2004. This Instrument applies to eligible persons who have served in various capacities, including operational, peacekeeping, hazardous, British nuclear test defence, warlike, and non-warlike services, and who have developed malignant neoplasm of the small intestine. The Instrument specifies the factors that must exist to connect such diseases or death with the service rendered. It is applicable nationally, reflecting the scope of the VEA and the MRCA, which cover claims for compensation from 1 July 2004 onwards. The Instrument does not include specific exclusions but is shaped by the sound medical-scientific evidence available. The Authority may extend or restrict its application through subordinate instruments, ensuring the medico-scientific quality of outcomes under these Acts. The Statement of Principles is compatible with human rights as it facilitates the assessment and determination of social security benefits, thereby promoting the rights to social security, an adequate standard of living, and the highest attainable standard of physical and mental health.

Key Provisions

The main operative sections of the Repatriation Medical Authority Instrument No. 1 of 2015 relate to the determination of a Statement of Principles concerning malignant neoplasm of the small intestine, as per subsection 196B(2) of the Veterans' Entitlements Act 1986 (VEA) (section 4). This Statement of Principles outlines the circumstances in which a reasonable hypothesis can be raised that the disease is connected to certain types of service under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). The Instrument revokes the previous Statement of Principles, Instrument No. 40 of 2004, and incorporates updates based on the latest medical-scientific evidence. The Instrument also specifies the circumstances under which medical treatment and compensation can be provided to eligible individuals. The Act imposes obligations on parties such as claimants and the Repatriation Commission to adhere to the specified conditions outlined in the Statement of Principles. It requires claimants to provide evidence that connects their malignant neoplasm of the small intestine with their service, in accordance with the factors set out in the Instrument. The Repatriation Commission is responsible for assessing claims based on these conditions, and the Veterans' Review Board and Administrative Appeals Tribunal have the authority to review these assessments. Breaches of the conditions outlined in the Statement of Principles can lead to civil and criminal consequences. While the Instrument does not explicitly state penalties for non-compliance, breaches of similar provisions in the VEA and MRCA may result in fines or other penalties as determined by the relevant courts. It is also important to note that the Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights, including the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health. In summary, the Repatriation Medical Authority Instrument No. 1 of 2015 outlines the conditions under which medical treatment and compensation can be provided to individuals with malignant neoplasm of the small intestine who have served in the armed forces. The Instrument imposes obligations on claimants and the Repatriation Commission to adhere to these conditions, and breaches may result in civil and criminal consequences. The Instrument is compatible with human rights as it promotes the rights of veterans, current and former Defence Force members, and their dependents.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Regulatory Standards
Compliance Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.